889884-94-0

Basic information

• Product Name: 2-Fluoro-7-hydroxynaphthalene
• Synonyms: 2-Fluoro-7-hydroxynaphthalene
• CAS NO: 889884-94-0
• Molecular Formula: C10H7FO
• Molecular Weight: 162.1603832
• Mol File: 889884-94-0.mol

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2-Fluoro-7-hydroxynaphthalene(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Fluoro-7-hydroxynaphthalene(889884-94-0)
• EPA Substance Registry System: 2-Fluoro-7-hydroxynaphthalene(889884-94-0)

Safety Data

• Hazardous Substances Data: 889884-94-0(Hazardous Substances Data)

Upstream product

• 62078-77-7 2-fluoro-7-methoxynaphthalene 
• 295779-87-2 2-fluoro-7-methoxy-3,4-dihydronaphthalen-1(2H)-one 
• 889884-93-9 toluene-4-sulfonic acid-7-fluoro-napthalene-2-yl-ester 
• 458-04-8 3-fluorophenylacetyl chloride 
• 331-25-9 (3-fluorophenyl)acetic acid 
• 456-41-7 1-(Bromomethyl)-3-fluorobenzene 
• 352-70-5 m-Fluorotoluene 
• 501-00-8 3-fluorophenylacetonitrile 
• 29419-15-6 7-fluoro-1,2,3,4-tetrahydronaphthalen-2-one 

Relevant articles and documents

Deleterious effect of 7-methyl group on glycosylation of 2-naphthols

C-Glycosylations of several 2-naphthols with different glycosyl donors have been investigated in the pursuit of the total synthesis of mayamycin (1). While glycosylations of the parent 2-naphthol are readily achievable, those of 5-methoxy-7-methyl-2-napht

Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition

The invention relates to a group of novel phenylpiperazine derivatives with a dual mode of action: serotonin reuptake inhibition and partial agonism on dopamine-D2 receptors. The invention also relates to the use of a compound disclosed herein for the manufacture of a medicament giving a beneficial effect. The compounds have the general formula (1): wherein the symbols have the meanings given in the specification. and tautomers, stereoisomers and N-oxides thereof, as well as pharmacologically acceptable salts, hydrates and solvates of said compounds of formula (1) and its tautomers, stereoisomers and N-oxides.